Literature DB >> 3532578

The biomedical and epidemiological characteristics of asbestos-related diseases: a review.

M Huncharek.   

Abstract

The purpose of this paper is to provide the reader with an overview of the biomedical and epidemiological characteristics of asbestos-related disease based upon currently available information. Epidemiological and experimental data developed over the past 20 years have greatly added to our knowledge of the biological effects of asbestos, particularly in relation to clinical disease. This information has substantially strengthened the evidence linking asbestos to specific health effects. Lung cancer and mesothelioma are clearly the most important asbestos-related causes of death among exposed individuals, although the accumulated data is suggestive of the existence of an excess risk of gastrointestinal and a variety of other neoplasms. Animal studies confirm the human epidemiological results and indicate that all commercially available fiber types are capable of producing lung cancer and mesothelioma. Experimental implantation and injection studies also show that the carcinogenicity of mineral fibers (including asbestos) is directly related to their dimensionality and not their chemical composition. Although the asbestos-related medical and scientific literature is voluminous, many issues related to the biological activity of asbestos fibers are as yet unresolved. Due to experimental and analytical limitations, questions concerning risk at low-level exposure, dose-response relationships, and individual susceptibility remain problematic.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3532578      PMCID: PMC2590075     

Source DB:  PubMed          Journal:  Yale J Biol Med        ISSN: 0044-0086


  41 in total

1.  Diffuse pleural mesothelioma and asbestos exposure in the North Western Cape Province.

Authors:  J C WAGNER; C A SLEGGS; P MARCHAND
Journal:  Br J Ind Med       Date:  1960-10

2.  FIBROSIS OF THE LUNGS DUE TO THE INHALATION OF ASBESTOS DUST.

Authors:  W E Cooke
Journal:  Br Med J       Date:  1924-07-26

3.  Mortality experience of insulation workers in the United States and Canada, 1943--1976.

Authors:  I J Selikoff; E C Hammond; H Seidman
Journal:  Ann N Y Acad Sci       Date:  1979       Impact factor: 5.691

4.  The medical surveillance of asbestos workers.

Authors:  H C Lewinsohn
Journal:  R Soc Health J       Date:  1972-04

5.  Respiratory symptoms in chrysotile asbestos mine and mill workers of Quebec.

Authors:  J C McDonald; M R Becklake; G Fournier-Massey; C E Rossiter
Journal:  Arch Environ Health       Date:  1972-05

6.  Asbestos pleural effusion.

Authors:  E A Gaensler; A I Kaplan
Journal:  Ann Intern Med       Date:  1971-02       Impact factor: 25.391

7.  Mortality from lung cancer and other causes among workers in an asbestos textile factory.

Authors:  J F Knox; S Holmes; R Doll; I D Hill
Journal:  Br J Ind Med       Date:  1968-10

8.  Risk of asbestosis in crocidolite and amosite mines in South Africa.

Authors:  L M Irwig; R S du Toit; G K Sluis-Cremer; A Solomon; R G Thomas; P P Hamel; I Webster; T Hastie
Journal:  Ann N Y Acad Sci       Date:  1979       Impact factor: 5.691

9.  Epidemiology of asbestos-related tumors.

Authors:  M Newhouse
Journal:  Semin Oncol       Date:  1981-09       Impact factor: 4.929

10.  The effects of the inhalation of asbestos in rats.

Authors:  J C Wagner; G Berry; J W Skidmore; V Timbrell
Journal:  Br J Cancer       Date:  1974-03       Impact factor: 7.640

View more
  4 in total

1.  Chrysotile asbestos exposure and mesothelioma.

Authors:  M Huncharek
Journal:  Br J Ind Med       Date:  1987-04

2.  Metastases in diffuse pleural mesothelioma: influence of histological type.

Authors:  M Huncharek; J Muscat
Journal:  Thorax       Date:  1987-11       Impact factor: 9.139

3.  Pleural mesothelioma in a brake mechanic.

Authors:  M Huncharek; J Muscat; J V Capotorto
Journal:  Br J Ind Med       Date:  1989-01

Review 4.  Perineal talc use and ovarian cancer: a critical review.

Authors:  Joshua E Muscat; Michael S Huncharek
Journal:  Eur J Cancer Prev       Date:  2008-04       Impact factor: 2.497

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.